Crunching the numbers for NAUT... Refresh in a moment for the full analysis.
Nautilus Biotechnology, Inc. (NAUT)
mixed
$2.95
Updated: 2026-04-13
51
TradeApes Score
hold
Financial Strength
50
Mixed
Operating Trend
50
Mixed
Valuation
40
Weak
Capital Allocation
50
Mixed
Risk
80
Strong
Key Findings
+
Strong liquidity — current assets more than 2× current liabilities
−
Low FCF yield — below 1%, price implies exceptional future growth
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Add to Watchlist
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.